Gujarat Terce Laboratories Balance Sheet Annual

BSE: 524314 | NSE: - | ISIN: INE499G01013 | Sector: Biotechnology & Drugs

75.88 -1.54 (-1.99%)Updated : 26 Nov 2024

Interim Data

Annual Data

Fiscal Period	2024	2023	2022	2021
Period End Date	Mar 24	Mar 23	Mar 22	Mar 21
Cash Equivalents	0.09	2.03	0.01	1.29
Cashand Short Term Investments	0.09	2.03	1.51	1.29
Accounts Receivable- Trade Net	5.66	7.99	5.47	5.10
Total Receivables Net	5.87	8.25	5.70	5.31
Total Inventory	3.98	4.43	6.43	3.74
Other Current Assets Total	1.27	1.34	1.83	1.62
Total Current Assets	11.22	16.05	15.48	11.95
Property/ Plant/ Equipment Total- Net	3.69	3.99	4.29	2.45
Long Term Investments	0.35	0.35	0.35	0.32
Note Receivable- Long Term	2.12	2.05	2.41	2.33
Other Long Term Assets Total	5.88	6.09	4.87	4.74
Total Assets	23.27	28.53	27.39	21.80
Accounts Payable	4.71	5.85	4.03	2.85
Current Portof LT Debt/ Capital Leases	2.94	0.83	0.60	0.17
Other Currentliabilities Total	4.49	4.95	4.82	4.48
Total Current Liabilities	12.14	16.61	13.21	11.64
Long Term Debt	0.93	1.46	2.30	0.42
Total Long Term Debt	0.93	1.46	2.30	0.42
Total Debt	3.87	7.27	6.67	4.74
Other Liabilities Total	3.10	3.60	3.34	2.08
Total Liabilities	16.17	21.66	18.86	14.14
Common Stock Total	7.42	7.42	1.11	7.42
Retained Earnings( Accumulated Deficit)	-0.31	-0.56	7.42	0.24
Total Equity	7.11	6.86	8.53	7.66
Total Liabilities Shareholders' Equity	23.27	28.53	27.39	21.80
Total Common Shares Outstanding	0.74	0.74	0.74	0.74
Tangible Book Valueper Share Common Eq	9.58	9.25	11.50	10.33
Notes Payable/ Short Term Debt	-	4.98	3.77	4.14
Short Term Investments	-	-	1.50	-